Treatment of chemotherapy extravasation: current status.
D000818:Animals; D000931:Antidotes / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000009:adverse effects*; D002199:Capillary Permeability; D004121:Dimethyl Sulfoxide / Q000627:therapeutic use; D004317:Doxorubicin / Q000009:adverse effects; D004342:Drug Hypersensitivity / Q000628:therapy; D006801:Humans; D009336:Necrosis; D012867:Skin / Q000473:pathology
D000931:Antidotes; D000970:Antineoplastic Agents; D004317:Doxorubicin; D004121:Dimethyl Sulfoxide